Related Experiment Video
Updated: Aug 5, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Focal scleroderma and severe cardiomyopathy. Patient report and brief review
E C Moore1, F Cohen, Z Farooki
1Division of Clinical Immunology, Children's Hospital of Michigan, Detroit 48201.
Insights
This study reports the first case of localized scleroderma with severe heart failure in an infant. Prednisone therapy successfully treated both cardiac and serological abnormalities, highlighting the potential for systemic involvement.
Area of Science:
- Pediatrics
- Rheumatology
- Cardiology
Background:
- Localized scleroderma is a connective tissue disease typically affecting the skin.
- Cardiac involvement is rare in localized scleroderma, more commonly seen in systemic sclerosis.
- Infantile cardiomyopathy presents a significant diagnostic and therapeutic challenge.
Observation:
- A 21-month-old infant presented with simultaneous localized scleroderma and severe cardiomyopathy.
- The infant exhibited cardiac dysfunction and elevated inflammatory markers, including rheumatoid factor, IgM, IgG, and erythrocyte sedimentation rate.
- Skin manifestations of scleroderma were also present.
Findings:
- Prednisone therapy led to the normalization of cardiac function and serological abnormalities.
- Significant, though incomplete, resolution of skin lesions was observed concurrently.
- This case represents the first documented instance of clinically significant cardiac involvement in localized scleroderma.
Implications:
- Localized scleroderma may be associated with serious internal organ involvement, particularly cardiac disease.
- Early recognition and treatment of cardiac complications are crucial in pediatric scleroderma cases.
- This case underscores the importance of considering systemic manifestations in patients with focal scleroderma.
Abstract:
A 21-month-old infant presented with simultaneous localized scleroderma and severe cardiomyopathy with heart failure. Cardiac abnormalities and serological changes (positive rheumatoid factor assay, elevated IgM and IgG levels, and elevated erythrocyte sedimentation rate) reverted to normal with prednisone therapy, and there was substantial, though incomplete, resolution of her skin changes during the same period. To our knowledge, this is the first patient with definite, clinically significant cardiac involvement associated with focal scleroderma. The possibility of internal organ involvement, including cardiac involvement, must be considered with focal scleroderma as well as with progressive systemic sclerosis.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

